Mediterranean Fish Vaccine Market to Grow at a CAGR of 10.2% to reach US$ 2,09,030.80 million from 2022 to 2030
The Mediterranean fish vaccine market size is expected to grow from US$ 96,323.46 million in 2022 to US$ 2,09,030.80 million by 2030; the market is estimated to register a CAGR of 10.2% from 2022 to 2030.
Market Insights and Analyst View:
The Mediterranean fish vaccine market is expected to grow significantly as countries in the region are striving to boost their aquaculture industries. Fisheries use fish vaccination machines or fish vaccinators to inject or administer vaccines to the fish. Technological developments have led to the introduction of more novel routes of administration to vaccinate fish. Also, fish vaccine companies have significantly shifted their focus on expanding their businesses to countries that are adjacent to the Mediterranean Sea. Government support in these countries to enhance their respective aquaculture businesses has encouraged companies in the fish vaccine market to expand their reach to these countries to cater to the demands of these businesses to manage the spread of infections to different fish species.
Economically, aquaculture or fisheries represent a considerable source of food and income in the Mediterranean region. In addition, marine activities have become a part of economic importance in the region. Aquaculture has particularly positively impacted the economies of the coastal countries in this region. The coast is surrounded by three regions—Asia, Europe, and Africa. Thus, many human activities are seen on a large scale in the coastal region, such as fishing, tourism, and urbanization. According to the World Wide Fund For Nature, ocean-related activities generate an annual economic value of US$ 450 billion. Thus, the growing income of fisheries businesses is likely to enable the rise in the purchase of different fish vaccines types in Mediterranean countries in the future.
Growth Drivers and Challenges:
European Commission funded US$ 7.88 million to the PerformFISH project, which was initiated to explore and tackle the major causes of stagnancy in the Mediterranean Marine Fish Farming (MMFF) sector. The PerformFISH has been making efforts to manage challenges associated with sea bass and sea bream in Mediterranean aquaculture. Furthermore, the project concentrates on developing a consumer-driven aquaculture production process by incorporating innovative approaches to promote sustainability and competitiveness in European sea bass and sea bream aquaculture businesses.
The European Union (EU), in the framework of Horizon 2020, funded Mediterranean Aquaculture Integrated Development (Media), a four-year Research and Innovation Action (RIA) project that was jointly approved with PerformFISH under the program SFS-23-2016—Improving the technical performance of Mediterranean aquaculture. MedAID aims to better the sustainability and competitiveness of the Mediterranean marine fish-farming sector, along with its value chain. Further, as part of the EU budget framework for 2021–2027, European Commission proposed a regulation for the continuation of the fund in June 2018, which is dedicated to the Integrated Maritime Policy and the Common Fisheries Policy. The new fund permits more flexibility in national programs. The SVC4MED is a four-year project funded by the Italian Ministry of Agricultural, Food and Forestry Policies, Directorate-General for Fisheries and Aquaculture (MIPAAF), and implemented by the Food and Agriculture Organization (FAO). The SVC4MED project aims to identify strategies to enhance the economic performance and social & environmental sustainability of capture fisheries and aquaculture value chains in the Mediterranean region. Thus, an increase in government initiatives to support developments in the aquaculture industry had been a major factor contributing to the Mediterranean fish vaccines market growth.
On the other hand, the global promotion of vaccines by animal healthcare firms subjects their products to several regulatory approval processes, resulting in some major complications. Vaccine approval procedures vary from nation to nation as per the regulating bodies, while many follow the laws of powerful organizations such as the US Food and Drug Administration (FDA) along with their national approval processes. Thus, strict regulatory policies for vaccine approvals hinder the growth of the market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Mediterranean Fish Vaccine Market: Strategic Insights
Market Size Value in US$ 96,323.46 million in 2022 Market Size Value by US$ 2,09,030.80 million by 2030 Growth rate CAGR of 10.2% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Mediterranean Fish Vaccine Market: Strategic Insights
| Market Size Value in | US$ 96,323.46 million in 2022 |
| Market Size Value by | US$ 2,09,030.80 million by 2030 |
| Growth rate | CAGR of 10.2% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
The Mediterranean fish vaccine market is segmented on the basis of vaccine type, species, route of administration, clinical indication, and country. Based on vaccine type, the market is segmented into inactivated vaccine, live-attenuated vaccine, toxoid vaccine, subunit vaccine, conjugate vaccine, and recombinant vector vaccine. In terms of species, the Mediterranean fish vaccine market is bifurcated into turbot, European anchovy and seabass, salmon, Mediterranean Sea bass, common dentex and common pandora, sea bream, rainbow wrasse, sparus aurata, trout, Mediterranean swordfish and bluefin tuna, grouper and amberjack and others. Based on the route of administration, the market is segmented into immersion vaccine, injection vaccine, and oral vaccine. The Mediterranean fish vaccine market, by clinical indication, is bifurcated into bacterial infection and viral infection. On the basis of country, the Mediterranean fish vaccine market is segmented into France, Italy, Spain, Egypt, Greece, Turkey, Israel, and Rest of the Mediterranean.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Segmental Analysis:
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Based on the route of administration, the Mediterranean fish vaccine market is segmented into immersion vaccine, injection vaccine, and oral vaccine. The injection vaccine segment held the largest market share in 2022. Injection is the most common method of vaccination. Injecting vaccines intramuscularly or intraperitoneally using a needle usually requires manual efforts. Compressed air devices have also been tested as another injection method, but they are not commonly used. Injection vaccines need fish of sufficiently large size, and even with automation, the vaccination becomes labor-intensive for fish farmers and stressful for the fish. These issues with the injection method have led to the development of several semiautomated techniques where the fish are forced through an enclosed space and, as they are wedged in, they are auto-injected with the vaccine. The use of these techniques is common, owing to the possibility of a large number of lesions at the injection site. Vaccination by injection delivers the most direct antigens to the immune system through intraperitoneal and intramuscular injection. The vaccine can be concentrated and delivered with adjuvants and other beneficial compounds (e.g., bacterial antigens/bacterial cells, carriers, etc.), which may not be possible with other methods. Further, the immersion vaccine segment is anticipated to register the highest CAGR during 2022–2030.
Mediterranean Fish Vaccine Market, by Route of Administration – 2022 and 2030
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Based on species, the Mediterranean fish vaccine market is segmented into turbot, European anchovy and seabass, salmon, Mediterranean Sea bass, common dentex and common pandora, sea bream, rainbow wrasse, sparus aurata, trout, Mediterranean swordfish and bluefin tuna, grouper and amberjack , and others (Beadlet anemone, Blacktailed wrasse, Black scorpionfish, Cardinalfish, Caulerpa prolifera, Damselfish, Deep-snouted pipefish, and Dotted seaslug)). The salmon segment held the largest market share in 2022. The Mediterranean Sea bass segment is anticipated to register the highest CAGR during 2022–2030
The Mediterranean fish vaccine market, by clinical indication, is segmented into bacterial infection and viral infection. The bacterial infection segment held the largest market share in 2022. It is further anticipated to register the highest CAGR during 2022–2030.
Regional Analysis:
Based on country, the Mediterranean fish vaccine market is divided into France, Italy, Spain, Egypt, Israel, Turkey, Greece, and Rest of the Mediterranean. The growth of the market in this region is driven by the flourishing aquaculture industry and increasing initiatives to enhance vaccine R&D. Among the above-listed countries, Israel is the fastest-growing country in the region and will witness highest CAGR. Spain has a prominent aquaculture sector among all European countries. Its aquaculture sector is also considered as a key contributor to the development of its food chain. The growth of this sector is attributed to a strong, competitive, advanced technological value chain. The AquaFuture Spain, an international meeting space, was created in 2022 to showcase the talents, potential, and quality of the aquaculture sector by bringing together professionals in the international aquaculture sector to share insights about the latest technological innovations and market strategies. Since then, Aquafuture Spain has been organizing international meets in the country. The meetings conducted would focus on the sustainable management of resources in the aquaculture sector. In 2023, the second International Aquaculture Industry Exhibition of AquaFuture Spain was held in Galicia, Spain, in March 2023, from 28 to 30. Such conferences in the country would create awareness regarding fish health management and promote fish vaccines to fish farmers, thereby propelling the fish vaccine market growth.
In March 2023, Fish Farm Feeder (FFF), a feeding systems manufacturer for aquaculture, showcased its new immersion fish vaccinator for hatcheries. The new fish vaccinator would reduce farmers' struggle with vaccination as fish are delivered to the machine filled with 50 L of a vaccine solution. FFF’s vaccinator is an automated machine for vaccination, which requires installation by a farmer, and it is likely to reduce vaccination time by a factor of 4–5. Such innovations are bolstering the extent of fish vaccination in Spain, leading to significant growth of the fish vaccine market in the country.
Industry Developments and Future Opportunities:
Various initiatives by key players operating in the Mediterranean Fish Vaccine Market are listed below:
- In February 2020, HIPRA conducted a conference in Monastir (Tunisia). The event was organized for Mediterranean producers and veterinarians from Tunisia and Algeria. The company addressed the issues that affect production in the Maghreb area. Addressing challenges faced by Mediterranean fish farmers, mainly associated with viral nervous necrosis and Pasteurellosis, has been one of the primary goals of the event.
- In August 2020, Elanco Animal Health Incorporated announced the complete acquisition of Bayer Animal Health for a value of US$ 6.89 billion. The acquisition enabled Elanco to expand its scale and capabilities, and strengthen its position in the animal health industry. In addition, it would enhance Elanco's innovation, portfolio, and productivity strategy. Through such acquisitions, the company aims to transform its portfolio to become a leader in the animal health industry.
- In July 2020, Zoetis Inc. announced the complete acquisition of Fish Vet Group, which was a part of Benchmark Holdings, PLC. The acquisition was made to add Fish Vet Group under the Pharmaq business segment of Zoetis. The strategic acquisition was made to strengthen Pharmaq's geographic reach, and enhance its diagnostics expertise and testing services, including environmental testing.
The developments made by the companies are helping the players to contribute actively to the growth of the animal genetic industry.
COVID-19 Impact:
Before the COVID-19 pandemic, fish vaccination was an integral part of fisheries. For many years, vaccination was practiced against infectious diseases. Several vaccines were introduced before the pandemic hit. For instance, in February 2018, Pharmaq (Zoetis, Inc) introduced its new vaccine developed against Nodavirus—Alpha Ject micro 1 Noda—in European countries, such as Spain, Italy, Croatia, and Greece. It is one of the most important diseases in the farming of sea bass. Thus, the launch of such new vaccines helped fish farmers in the Mediterranean fight against common viral diseases affecting farmed sea bass. The fish vaccine market grew abundantly before the COVID-19 pandemic, allowing farmers to continue fisheries without worries.
The COVID-19 crisis led o disruptions in the development of fish vaccines in 2020, resulting in the loss of revenues for many companies. Moreover, fish farmers faced the fear of disease transmission to fish species due to the lack of studies on SARS-CoV-2. The increasing extent of the threat compelled fish vaccine market players to fully resume their development operations later in 2021–2022. The article “Development of autogenous vaccines for farmed European seabass against Aeromonas veronii using zebrafish as a model for efficacy assessment” released in 2022 talks about the development of a bivalent vaccine, which was based on two phenotypically distinct strains of the pathogen. The vaccine was developed against Aeromonas veronii bv. Sobria, an emerging pathogen in European seabass cultured in the Mediterranean Sea, which is causing significant problems in the Greek and Turkish aquaculture industry.
Competitive Landscape and Key Companies:
A few of the prominent players operating in the Mediterranean fish vaccine market include Zoetis Inc, Merck & Co Inc, HIPRA SA, ICTYODEV SAS, Acuipharma Aquaculture Health SL, Phibro Animal Health Corp, Vaxxinova International BV, Kyoto Biken Laboratories Inc, Elanco Animal Health Inc, and Ceva SA. These companies focus on new product launches and geographic expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. Their global presence allows them to serve a large set of customers, subsequently allowing them to expand their market share.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Vaccine Type, Route of Administration, Species, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Driving factors such as government initiatives to develop the Mediterranean aquaculture industry and the surging demand for aquatic animal-derived food products propel market growth. However, strict regulatory policies for the approval of vaccines hinder market growth.
The Mediterranean fish vaccine market is analyzed based on the key countries that have good aquaculture industries, which include France, Italy, Spain, Egypt, Greece, Turkey, Israel, and the Rest of the Mediterranean.
Zoetis Inc; Merck & Co Inc; HIPRA SA; ICTYODEV SAS; Acuipharma Aquaculture Health SL; Phibro Animal Health Corp; Vaxxinova International BV; Kyoto Biken Laboratories Inc; Elanco Animal Health Inc, and Ceva SA are the major companies operating in the market.
The “Mediterranean Fish Vaccine Market” is segmented on the basis of vaccine type, species, route of administration, clinical indication, and country. Based on the vaccine type, the market is bifurcated into inactivated vaccine, live-attenuated vaccine, toxoid vaccine, subunit vaccine, conjugate vaccine, and recombinant vector vaccine. Based on species, the Mediterranean fish vaccine market is bifurcated into turbot, European anchovy and seabass, salmon, Mediterranean sea bass, common dentex and common pandora, sea bream, rainbow wrasse, Sparus aurata, trout, Mediterranean swordfish and bluefin tuna, grouper and amberjack, and others. In terms of route of administration, the market is segmented into immersion vaccine, injection vaccine, and oral vaccine. And based on clinical indication, the market is classified as bacterial infection and viral infection.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Mediterranean Fish Vaccine Market – Market Landscape
4.1 Overview
4.1.1 Mediterranean Region PEST Analysis
4.2 Mediterranean Fish Species
4.3 List of Mediterranean Fish Species
5. Mediterranean Fish Vaccine Market – Regional Analysis
5.1 Key Market Drivers:
5.1.1 Government Initiatives to Develop Mediterranean Aquaculture Industry
5.1.2 Surging Demand for Aquatic Animal-Derived Food Products
5.2 Key Market Restraints:
5.2.1 Strict Regulatory Policies for Approval of Vaccines
5.3 Key Market Opportunities:
5.3.1 Development of Novel Vaccines
5.4 Future Trends:
5.4.1 Shift from Conventional Vaccines to DNA Vaccines
5.5 Impact Analysis:
6. Mediterranean Fish Vaccine Market – Regional Analysis
6.1 Mediterranean Fish Vaccine Market Revenue Forecast and Analysis
7. Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 – by Vaccine Type
7.1 Overview
7.2 Mediterranean Fish Vaccine Market Revenue Share, by Vaccine Type 2022 & 2030 (%)
7.3 Inactivated Vaccine
7.3.1 Overview
7.3.2 Inactivated Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Live Attenuated Vaccine
7.4.1 Overview
7.4.2 Live Attenuated Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Toxoid Vaccine
7.5.1 Overview
7.5.2 Toxoid Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Subunit Vaccine
7.6.1 Overview
7.6.2 Subunit Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Conjugate Vaccine
7.7.1 Overview
7.7.2 Conjugate Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Recombinant Vector Vaccine
7.8.1 Overview
7.8.2 Recombinant Vector Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
8. Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 – by Route of Administration
8.1 Overview
8.2 Mediterranean Fish Vaccine Market Revenue Share, by Route of Administration 2022 & 2030 (%)
8.3 Immersion Vaccine
8.3.1 Overview
8.3.2 Immersion Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Injection Vaccine
8.4.1 Overview
8.4.2 Injection Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Oral Vaccine
8.5.1 Overview
8.5.2 Oral Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9. Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 – by Species.
9.1 Overview
9.2 Mediterranean Fish Vaccine Market Revenue Share, by Species 2022 & 2030 (%)
9.3 Turbot
9.3.1 Turbot: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.4 European Anchovy and Seabass
9.4.1 European Anchovy and Seabass: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Salmon
9.5.1 Salmon: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Mediterranean Sea Bass
9.6.1 Mediterranean Sea Bass: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.7 Common Dentex and Common Pandora
9.7.1 Common Dentex and Common Pandora: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.8 Sea Bream
9.8.1 Sea Bream: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.9 Rainbow Wrasse
9.9.1 Rainbow Wrasse: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.10 Sparus aurata
9.10.1 Sparus aurata: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.11 Trout
9.11.1 Trout: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.12 Mediterranean Swordfish and Bluefin Tuna
9.12.1 Mediterranean Swordfish and Bluefin Tuna: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.13 Grouper and Amberjack
9.13.1 Grouper and Amberjack: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
9.14 Others
9.14.1 Others: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
10. Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 – by Clinical Indication
10.1 Overview
10.2 Mediterranean Fish Vaccine Market Revenue Share, by Clinical Indication 2022 & 2030 (%)
10.3 Bacterial Infection
10.3.1 Overview
10.3.2 Bacterial Infection: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Viral Infection
10.4.1 Overview
10.4.2 Viral Infection: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
11. Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 – Geographic Analysis
11.1 Mediterranean Fish Vaccine Market, Revenue and Forecast to 2030
11.1.1 Overview
11.1.2 Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.1 Mediterranean Fish Vaccine Market, by Vaccine Type
11.1.2.2 Mediterranean Fish Vaccine Market, by Route of Administration
11.1.2.3 Mediterranean Fish Vaccine Market, by Species
11.1.2.4 Mediterranean Fish Vaccine Market, by Clinical Indication
11.1.2.4.1 Mediterranean Fish Vaccine Market, by Bacterial Infection
11.1.2.4.2 Mediterranean Fish Vaccine Market, by Bacterial Infection
11.1.2.5 Mediterranean Fish Vaccine Market by Country
11.1.2.5.1 France
11.1.2.5.1.1 Overview
11.1.2.5.1.2 France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.5.1.2.1 France: Mediterranean Fish Vaccine Market, by Vaccine Type
11.1.2.5.1.2.2 France: Mediterranean Fish Vaccine Market, by Route of Administration
11.1.2.5.1.2.3 France: Mediterranean Fish Vaccine Market, by Species
11.1.2.5.1.2.4 France: Mediterranean Fish Vaccine Market, by Clinical Indication
11.1.2.5.1.2.4.1 France: Mediterranean Fish Vaccine Market, by Bacterial Infection
11.1.2.5.1.2.4.2 France: Mediterranean Fish Vaccine Market, by Viral Infection
11.1.2.5.2 Italy
11.1.2.5.2.1 Overview
11.1.2.5.2.2 Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.5.2.2.1 Italy: Mediterranean Fish Vaccine Market, by Vaccine Type
11.1.2.5.2.2.2 Italy: Mediterranean Fish Vaccine Market, by Route of Administration
11.1.2.5.2.2.3 Italy: Mediterranean Fish Vaccine Market, by Species
11.1.2.5.2.2.4 Italy: Mediterranean Fish Vaccine Market, by Clinical Indication
11.1.2.5.2.2.4.1 Italy: Mediterranean Fish Vaccine Market, by Bacterial Infection
11.1.2.5.2.2.4.2 Italy: Mediterranean Fish Vaccine Market, by Viral Infection
11.1.2.5.3 Spain
11.1.2.5.3.1 Overview
11.1.2.5.3.2 Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.5.3.2.1 Spain: Mediterranean Fish Vaccine Market, by Vaccine Type
11.1.2.5.3.2.2 Spain: Mediterranean Fish Vaccine Market, by Route of Administration
11.1.2.5.3.2.3 Spain: Mediterranean Fish Vaccine Market, by Species
11.1.2.5.3.2.4 Spain: Mediterranean Fish Vaccine Market, by Clinical Indication
11.1.2.5.3.2.4.1 Spain: Mediterranean Fish Vaccine Market, by Bacterial Infection
11.1.2.5.3.2.4.2 Spain: Mediterranean Fish Vaccine Market, by Viral Infection
11.1.2.5.4 Egypt
11.1.2.5.4.1 Overview
11.1.2.5.4.2 Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.5.4.2.1 Egypt: Mediterranean Fish Vaccine Market, by Vaccine Type
11.1.2.5.4.2.2 Egypt: Mediterranean Fish Vaccine Market, by Route of Administration
11.1.2.5.4.2.3 Egypt: Mediterranean Fish Vaccine Market, by Species
11.1.2.5.4.2.4 Egypt: Mediterranean Fish Vaccine Market, by Clinical Indication
11.1.2.5.4.2.4.1 Egypt: Mediterranean Fish Vaccine Market, by Bacterial Infection
11.1.2.5.4.2.4.2 Egypt: Mediterranean Fish Vaccine Market, by Viral Infection
11.1.2.5.5 Israel
11.1.2.5.5.1 Overview
11.1.2.5.5.2 Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.5.5.2.1 Israel: Mediterranean Fish Vaccine Market, by Vaccine Type
11.1.2.5.5.2.2 Israel: Mediterranean Fish Vaccine Market, by Route of Administration
11.1.2.5.5.2.3 Israel: Mediterranean Fish Vaccine Market, by Species
11.1.2.5.5.2.4 Israel: Mediterranean Fish Vaccine Market, by Clinical Indication
11.1.2.5.5.2.4.1 Israel: Mediterranean Fish Vaccine Market, by Bacterial Infection
11.1.2.5.5.2.4.2 Israel: Mediterranean Fish Vaccine Market, by Viral Infection
11.1.2.5.6 Turkey
11.1.2.5.6.1 Overview
11.1.2.5.6.2 Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.5.6.2.1 Turkey: Mediterranean Fish Vaccine Market, by Vaccine Type
11.1.2.5.6.2.2 Turkey: Mediterranean Fish Vaccine Market, by Route of Administration
11.1.2.5.6.2.3 Turkey: Mediterranean Fish Vaccine Market, by Species
11.1.2.5.6.2.4 Turkey: Mediterranean Fish Vaccine Market, by Clinical Indication
11.1.2.5.6.2.4.1 Turkey: Mediterranean Fish Vaccine Market, by Bacterial Infection
11.1.2.5.6.2.4.2 Turkey: Mediterranean Fish Vaccine Market, by Viral Infection
11.1.2.5.7 Greece
11.1.2.5.7.1 Overview
11.1.2.5.7.2 Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.5.7.2.1 Greece: Mediterranean Fish Vaccine Market, by Vaccine Type
11.1.2.5.7.2.2 Greece: Mediterranean Fish Vaccine Market, by Route of Administration
11.1.2.5.7.2.3 Greece: Mediterranean Fish Vaccine Market, by Species
11.1.2.5.7.2.4 Greece: Mediterranean Fish Vaccine Market, by Clinical Indication
11.1.2.5.7.2.4.1 Greece: Mediterranean Fish Vaccine Market, by Bacterial Infection
11.1.2.5.7.2.4.2 Greece: Mediterranean Fish Vaccine Market, by Viral Infection
11.1.2.5.8 Rest of the Mediterranean
11.1.2.5.8.1 Overview
11.1.2.5.8.2 Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.5.8.2.1 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Vaccine Type
11.1.2.5.8.2.2 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Route of Administration
11.1.2.5.8.2.3 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Species
11.1.2.5.8.2.4 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Clinical Indication
11.1.2.5.8.2.4.1 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Bacterial Infection
11.1.2.5.8.2.4.2 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Viral Infection
12. Pre and Post COVID-19 Impact
12.1 Pre and Post COVID-19 Impact
13. Mediterranean Fist Vaccine Market – Industry Landscape
13.1 Overview
13.2 Growth Strategies in Mediterranean Fish Vaccine Market
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Zoetis Inc
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Merck & Co Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 HIPRA SA
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 ICTYODEV SAS
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 ACUIPHARMA AQUACULTURE HEALTH SL
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Phibro Animal Health Corp
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Vaxxinova International BV
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Kyoto Biken Laboratories Inc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Elanco Animal Health Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Ceva SA
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
List of Tables
Table 1. Mediterranean Fish Vaccine Market Segmentation
Table 2. Species of Fishes, Disease and Available Vaccine –
Table 3. Bacterial Pathogens of Fishes –
Table 4. USDA Approved Bacterial Fish Vaccines –
Table 5. Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Vaccine Type
Table 6. Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 7. Mediterranean Fish Vaccine Market Revenue and Forecast To 2030 (US$ Mn) – Species
Table 8. Mediterranean Fish Vaccine Market Revenue and Forecast To 2030 (US$ Mn) – Clinical Indication
Table 9. Mediterranean Fish Vaccine Market Revenue and Forecast To 2030 (US$ Mn) – Bacterial Infection
Table 10. Mediterranean Fish Vaccine Market Revenue and Forecast To 2030 (US$ Mn) – Viral Infection
Table 11. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Vaccine Type
Table 12. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 13. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Species
Table 14. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Clinical Indication
Table 15. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Bacterial Infection
Table 16. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Viral Infection
Table 17. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Vaccine Type
Table 18. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 19. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Species
Table 20. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Clinical Indication
Table 21. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Bacterial Infection
Table 22. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Viral Infection
Table 23. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Vaccine Type
Table 24. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 25. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Species
Table 26. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Clinical Indication
Table 27. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Bacterial Infection
Table 28. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Viral Infection
Table 29. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Vaccine Type
Table 30. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 31. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Species
Table 32. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Clinical Indication
Table 33. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Bacterial Infection
Table 34. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Viral Infection
Table 35. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Vaccine Type
Table 36. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 37. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Species
Table 38. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Clinical Indication
Table 39. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Bacterial Infection
Table 40. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Viral Infection
Table 41. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Vaccine Type
Table 42. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 43. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Species
Table 44. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Clinical Indication
Table 45. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Bacterial Infection
Table 46. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Viral Infection
Table 47. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Vaccine Type
Table 48. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 49. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Species
Table 50. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Clinical Indication
Table 51. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Bacterial Infection
Table 52. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Viral Infection
Table 53. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Vaccine Type
Table 54. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 55. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) –Species
Table 56. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) –Clinical Indication
Table 57. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Bacterial Infection
Table 58. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) – Viral Infection
Table 59. Recent Inorganic Growth Strategies in the Mediterranean Fish Vaccine Market
Table 60. Recent Organic Growth Strategies in Mediterranean fish vaccine Market
Table 61. Glossary of Terms
List of Figures
Figure 1. Mediterranean Fish Vaccine Market Segmentation, By Region
Figure 2. Mediterranean Region: PEST Analysis
Figure 3. Mediterranean Fish Vaccine Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Mediterranean Fish Vaccine Market – Revenue Forecast and Analysis – 2020–2030
Figure 6. Mediterranean Fish Vaccine Market Revenue Share, by Vaccine Type 2022 & 2030 (%)
Figure 7. Inactivated Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Live Attenuated Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Toxoid Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Subunit Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Conjugate Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Recombinant Vector Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Mediterranean Fish Vaccine Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 14. Inactivated Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Injection Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Toxoid Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Mediterranean Fish Vaccine Market Revenue Share, by Species 2022 & 2030 (%)
Figure 18. Turbot: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. European Anchovy and Seabass: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Salmon: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Mediterranean Sea Bass: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Common Dentex and Common Pandora: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Sea Bream: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Rainbow Wrasse: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Sparus aurata: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Trout: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Mediterranean Swordfish and Bluefin Tuna: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Grouper and Amberjack: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Others: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Mediterranean Fish Vaccine Market Revenue Share, by Clinical Indication 2022 & 2030 (%)
Figure 31. Bacterial Infection: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Viral Infection: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
Figure 33. Mediterranean Fish Vaccine Market, By Region, 2022 ($Mn)
Figure 34. Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. Mediterranean Fish Vaccine Market, By Key Countries, 2022 And 2030 (%)
Figure 36. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 38. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 40. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 41. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 42. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 44. Pre and Post COVID-19 Impact on Mediterranean Fish Vaccine Market
Figure 45. Growth Strategies in Mediterranean Fish Vaccine Market
The List of Companies - Mediterranean Fish Vaccine Market
- Zoetis Inc.
- Merck & Co Inc
- HIPRA SA
- ICTYODEV SAS
- Acuipharma Aquaculture Health SL
- Phibro Animal Health Corp
- Vaxxinova International BV
- Kyoto Biken Laboratories Inc
- Elanco Animal Health Inc
- Ceva SA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For